Executive Orders
EO 14337 Revocation of Executive Order on Competition
Revokes EO 14036 of July 9, 2021, which had established a federal framework for promoting competition across key industries. The order removes directives that previously required agencies to take specific actions aimed at curbing consolidation and enhancing consumer protections. Signals a policy shift toward alternative approaches for addressing competition and market fairness. The revocation reflects the administration’s reassessment of regulatory priorities in light of evolving economic and legal conditions.
EO 14336 Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
Strengthens U.S. pharmaceutical security by directing the federal government to build and maintain a strategic reserve of critical active pharmaceutical ingredients (APIs). Ensures preparedness against supply chain disruptions, public health emergencies, and foreign dependencies in essential medicines. Builds upon EO 13944 (August 6, 2020) by expanding federal procurement and stockpiling authority to safeguard the nation’s health infrastructure. Reinforces the administration’s commitment to resilience in drug manufacturing, national security, and public safety.
EO 14335 Enabling Competition in the Commercial Space Industry
Promotes innovation, competitiveness, and private-sector leadership in the growing commercial space sector. Directs federal agencies to reduce regulatory barriers, streamline licensing, and expand opportunities for American companies to participate in satellite deployment, space transportation, and emerging orbital services. Encourages public-private partnerships to accelerate technological advancement and strengthen U.S. leadership in space exploration and commerce. The order underscores the strategic importance of fostering a robust and competitive space industry to national security and economic growth.
Looking to Grow Your Business?
I’m looking to partner with 2 businesses generating under $3M in annual revenue that want a done-for-you system to double their income by attracting high-quality leads, while firing clients who drain your time, money, and energy.
If you’re ready to grow,
US Congress
H.R.1316 Maintaining American Superiority by Improving Export Control Transparency Act of 2025
Introduced by Rep. Ronny Jackson (R-TX-13), this law strengthens U.S. oversight of export controls to safeguard national security and maintain global competitiveness. It enhances transparency requirements within the export licensing process, mandating clearer reporting and accountability from federal agencies overseeing sensitive technologies. The Act directs the Departments of State, Commerce, and Defense to improve coordination on export control enforcement and requires regular updates to Congress on trends in foreign acquisitions of U.S. technologies. It also seeks to provide businesses with greater clarity on compliance obligations while ensuring adversaries cannot exploit regulatory loopholes.
